Medtecs International Corporation Limited (SGX:546)
Singapore · Delayed Price · Currency is SGD 0.1160
0.00 (0.00%)
At close: Aug 14, 2026
SGXC:546 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 84.84 | 78.97 | 54.42 | 52.64 | 56.24 | 144.16 | |
Revenue Growth | 29.86% | 45.10% | 3.39% | -6.41% | -60.98% | -63.99% |
Cost of Revenue | 72.48 | 66.32 | 47.54 | 46.68 | 59.58 | 100.68 |
Gross Profit | 12.37 | 12.65 | 6.88 | 5.96 | -3.34 | 43.48 |
Selling, General & Admin | 17.04 | 16.26 | 23.28 | 24.94 | 29.73 | 27.47 |
Operating Expenses | 18.44 | 19.33 | 35.36 | 30.95 | 29.73 | 27.47 |
Operating Income | -6.07 | -6.69 | -28.47 | -24.99 | -33.07 | 16.01 |
Interest Expense | -0.77 | -0.77 | -0.76 | -0.74 | -0.82 | -0.85 |
Interest & Investment Income | 0.92 | 0.92 | 1.46 | 1.43 | 0.91 | 0.03 |
Currency Exchange Gain (Loss) | -0.32 | -0.32 | 0.63 | -0.04 | 0.83 | 0.03 |
Other Non Operating Income (Expenses) | 0.97 | 1.35 | 1.08 | 1.27 | 1.21 | 1.64 |
EBT Excluding Unusual Items | -5.28 | -5.51 | -26.07 | -23.07 | -30.94 | 16.86 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 2.23 | 0.35 | 0.17 | 0.06 |
Other Unusual Items | 0.36 | 0.36 | 0.39 | 0.21 | 0.04 | - |
Pretax Income | -4.91 | -5.14 | -23.44 | -22.52 | -30.65 | 16.92 |
Income Tax Expense | -0.44 | -0.38 | 0.51 | -0.03 | -1.39 | 0.41 |
Earnings From Continuing Operations | -4.48 | -4.76 | -23.95 | -22.49 | -29.26 | 16.51 |
Minority Interest in Earnings | -0.01 | -0.01 | 1.53 | 1.42 | 0.67 | 0.83 |
Net Income | -4.48 | -4.77 | -22.42 | -21.07 | -28.6 | 17.34 |
Net Income to Common | -4.48 | -4.77 | -22.42 | -21.07 | -28.6 | 17.34 |
Net Income Growth | - | - | - | - | - | -86.83% |
Shares Outstanding (Basic) | - | 545 | 545 | 545 | 545 | 547 |
Shares Outstanding (Diluted) | - | 545 | 545 | 545 | 545 | 547 |
Shares Change | - | - | - | -0.07% | -0.30% | -0.46% |
EPS (Basic) | - | -0.01 | -0.04 | -0.04 | -0.05 | 0.03 |
EPS (Diluted) | - | -0.01 | -0.04 | -0.04 | -0.05 | 0.03 |
EPS Growth | - | - | - | - | - | -86.77% |
Free Cash Flow | -3.44 | -9.04 | -0.98 | -12.08 | -16.26 | 13.73 |
Free Cash Flow Per Share | - | -0.02 | -0.00 | -0.02 | -0.03 | 0.03 |
Dividend Per Share | - | - | - | - | - | 0.006 |
Dividend Growth | - | - | - | - | - | -88.07% |
Gross Margin | 14.57% | 16.01% | 12.65% | 11.32% | -5.93% | 30.16% |
Operating Margin | -7.16% | -8.47% | -52.32% | -47.47% | -58.80% | 11.11% |
Profit Margin | -5.28% | -6.03% | -41.20% | -40.02% | -50.84% | 12.03% |
Free Cash Flow Margin | -4.05% | -11.45% | -1.80% | -22.94% | -28.91% | 9.52% |
EBITDA | -2.58 | -3.11 | -24.09 | -20.76 | -29.78 | 19.69 |
EBITDA Margin | -3.03% | -3.94% | -44.26% | -39.44% | -52.95% | 13.66% |
D&A For EBITDA | 3.5 | 3.58 | 4.39 | 4.23 | 3.29 | 3.68 |
EBIT | -6.07 | -6.69 | -28.47 | -24.99 | -33.07 | 16.01 |
EBIT Margin | -7.16% | -8.47% | -52.32% | -47.47% | -58.80% | 11.11% |
Effective Tax Rate | - | - | - | - | - | 2.41% |
Advertising Expenses | - | - | - | - | - | 1.44 |